CALCA and migraine disorder: Nevertheless, despite the revolution brought by CGRP-mAbs and gepants in migraine armamentarium, a significant percentage of patients (close to 40%) still remains burdened by an unsatisfactory response, suggesting that other molecules or pathways may play a critical role, with an extent of involvement varying among different migraine patients or, possibly, migraine attacks [8,9].